SEI Investments
NYMX

SEI Investments’s Nymox Pharmaceutical Corp NYMX Stock Holding History

SEI Investments’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,322
Closed -$4K – 3576
2018
Q2 		$4K Buy
+1,322
New +$5.08K ﹤0.01% 3230

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

SEI Investments's NYMX Position: Q3 2018 in Review

SEI Investments sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2018, closing a stake of 1,322 shares — an estimated $4K sold.

SEI Investments first reported a position in NYMX in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 46 funds tracked by Wall St. Rank hold NYMX as of Q3 2018.

  • SEI Investments reported no remaining Nymox Pharmaceutical Corp position as of Q3 2018 after selling out during the quarter.
  • SEI Investments sold 1,322 Nymox Pharmaceutical Corp shares in Q3 2018, an estimated $4K.
  • SEI Investments first reported a position in Nymox Pharmaceutical Corp in Q2 2018 and held it in 1 quarter.
  • SEI Investments's Nymox Pharmaceutical Corp position peaked at $4K in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.